menu
    • menu

    Company profile for Apollomics Inc

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Apollomics, we are a purpose driven company imagining a world without cancer. We let science drive our decision making to advance our programs. We believe in the power of partnerships to enhance our pipeline and broaden the patient populations we serve.Our existing pipeline consists of six development-stage assets including three novel, humanized monoclonal antibodies that restore the body’s immune system to recognize and...
    At Apollomics, we are a purpose driven company imagining a world without cancer. We let science drive our decision making to advance our programs. We believe in the power of partnerships to enhance our pipeline and broaden the patient populations we serve.Our existing pipeline consists of six development-stage assets including three novel, humanized monoclonal antibodies that restore the body’s immune system to recognize and kill cancer cells, and three targeted therapies against uncontrolled growth signaling pathways.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Apollomics IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    989 East Hillsdale Blvd, Suite 220 Foster City, CA 94588-8506
    Telephone
    Telephone
    +1.925.272.4090
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.apollomicsinc.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/apollomics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/apollomics

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Apollomics Announces Settlement Of Cayman Litigation
    Apollomics Announces Settlement Of Cayman Litigation

    19 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/19/3191516/0/en/Apollomics-Announces-Settlement-of-Cayman-Litigation.html

    GLOBENEWSWIRE
    19 Nov 2025
    Share Share
    Apollomics Maintains Nasdaq Listing After Hearing Cancellation
    Apollomics Maintains Nasdaq Listing After Hearing Cancellation

    15 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/15/3167416/0/en/Apollomics-Announces-Continued-Listing-on-The-Nasdaq-Stock-Market-Following-Hearing-Cancellation.html

    GLOBENEWSWIRE
    15 Oct 2025
    Share Share
    Apollomics Company Operational Continuity Update
    Apollomics Company Operational Continuity Update

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3165856/0/en/Apollomics-Inc-Company-Operational-Continuity-Update.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    Apollomics Reports 2024 Financial Results and Clinical Updates
    Apollomics Reports 2024 Financial Results and Clinical Updates

    03 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/03/3055586/0/en/Apollomics-Reports-Full-Year-2024-Financial-Results-and-Highlights-Clinical-Updates-and-Business-Progress.html

    GLOBENEWSWIRE
    03 Apr 2025
    Share Share
    Apollomics and LaunXP partner on Vebreltinib development
    Apollomics and LaunXP partner on Vebreltinib development

    31 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/31/3052245/0/en/Apollomics-and-LaunXP-Announce-Development-and-Commercialization-Agreement-for-Vebreltinib.html

    GLOBENEWSWIRE
    31 Mar 2025
    Share Share
    Apollomics, after giving up on leukemia drug, posts ph. 3 fail
    Apollomics, after giving up on leukemia drug, posts ph. 3 fail

    20 Dec 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/apollomics-after-giving-glycomimetics-leukemia-drug-posts-another-phase-3-fail

    FIERCE BIOTECH
    20 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search